eMedicine Specialties > Orthopedic Surgery > Foot & Ankle

Charcot Arthropathy

Author: Mrugeshkumar Shah, MD, MPH, Staff Physician, Physical Medicine and Rehabilitation, Massachusetts General Hospital/Spaulding Rehabilitation Hospital
Coauthor(s): Walter Panis, MD, Clinical Instructor, Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School
Contributor Information and Disclosures

Updated: Aug 29, 2007

Introduction

In 1703, William Musgrave first described a neuropathic joint as an arthralgia caused by venereal disease.1 In 1868, Jean-Martin Charcot gave the first detailed description of the neuropathic aspect of this disease; hence, the condition is named after him.2 Charcot noted this disease process as a complication of syphilis. Syphilis was believed to be the most common cause of Charcot arthropathy until 1936, when Jordan linked it to diabetes. Diabetes is now considered to be the most common etiology of Charcot arthropathy.

Problem

Also called Charcot joint or neuropathic joint, Charcot arthropathy is a progressive condition of the musculoskeletal system that is characterized by joint dislocations, pathologic fractures, and debilitating deformities. This disorder results in progressive destruction of bone and soft tissues at weight-bearing joints; in its most severe form, it may cause significant disruption of the bony architecture. Charcot arthropathy can occur at any joint; however, it occurs most commonly in the lower extremity, at the foot and ankle.

Frequency

The prevalence of Charcot arthropathy ranges from 0.1% to as high as 13% in specialized foot clinics. In patients with diabetes, the incidence of acute Charcot arthropathy of the foot and ankle ranges from 0.15-2.5%.

Epidemiologic studies do not distinguish between acute and postacute disease. Bilateral disease occurs in less than 10% of patients. Recurrence of disease occurs in less than 5% of patients. Some studies indicate that men and women are equally affected, while others report a 3:1 predilection for males.

Etiology

Any condition that causes sensory or autonomic neuropathy can lead to a Charcot joint. Charcot arthropathy occurs as a complication of diabetes, syphilis, chronic alcoholism, leprosy, meningomyelocele, spinal cord injury, syringomyelia, renal dialysis, and congenital insensitivity to pain. Diabetes is considered to be the most common cause of Charcot arthropathy.

Pathophysiology

The exact nature of Charcot arthropathy remains unknown, but the following major theories exist regarding the pathophysiology of this condition:

  • Neurotraumatic theory - This theory states that Charcot arthropathy is caused by an unperceived trauma or injury to an insensate foot. The sensory neuropathy renders the patient unaware of the osseous destruction that occurs with ambulation. This microtrauma leads to progressive destruction and damage to bone and joints.
  • Neurovascular theory - This theory suggests that the underlying condition leads to the development of autonomic neuropathy, causing the extremity to receive an increased blood flow. This in turn results in a mismatch in bone destruction and synthesis, leading to osteopenia.

Charcot arthropathy most likely results from a combination of the processes described in the above theories. The autonomic neuropathy leads to abnormal bone formation, and the sensory neuropathy leads to an insensate joint that is susceptible to trauma. The development of abnormal bone with no ability to protect the joint results in gradual bone fracture and in the subluxation of the joint.

Presentation

The clinical presentation of Charcot arthropathy can vary widely depending on the stage of the disease. Thus, symptoms can range from mild swelling and no deformity to moderate deformity with significant swelling.

Acute Charcot arthropathy almost always presents with signs of inflammation. Profound unilateral swelling, an increase in local skin temperature (generally, an increase of 3-7 º above the nonaffected foot's skin temperature), erythema, joint effusion, and bone resorption in an insensate foot are present. These characteristics, in the presence of intact skin and a loss of protective sensation, are often pathognomonic of acute Charcot arthropathy.

Pain can occur in more than 75% of patients; however, the pain's severity is significantly less than would be expected based on the severity of the clinical and/or radiographic findings. Instability and loss of joint function also may be present. Passive movement of the joint may reveal a "loose bag of bones." Approximately 40% of patients with acute Charcot arthropathy have concomitant ulceration, which complicates the diagnosis and raises concerns that osteomyelitis is present.

Indications

Surgery is warranted in less than 25% of cases and generally is used as a preventive measure. Surgery is performed when a deformity places the extremity at risk of ulceration and when the extremity cannot be safely protected in accommodative footwear. The goal of reconstruction is to create a stable, plantigrade foot that can be appropriately protected in accommodative footwear and that can support ambulation. Surgery is indicated for malaligned, unstable, or nonreducible fractures or dislocations, as well as for cases in which nonsurgical means fail.

Relevant Anatomy

Numerous classification systems based on clinical, radiographic, and anatomic pathology describe Charcot arthropathy. Anatomic classification systems are the most commonly used and have the added benefit of predicting outcome and prognosis. The most commonly used anatomic system is described by Saunders and Mrdjencovich.3 Based on the location of the arthropathy, their system classifies Charcot arthropathy into 5 different patterns, as follows: 

  • Pattern 1 involves the forefoot, which includes the interphalangeal joints, the phalanges, and the metatarsophalangeal joint.
  • Pattern 2 involves the tarsometatarsal joint.
  • Pattern 3 involves the cuneonavicular, talonavicular, and calcaneocuboid articulations.
  • Pattern 4 involves the talocrural, or ankle, joint, which is the articulation of the tibia, the fibula, and the talus.
  • Pattern 5 involves the posterior calcaneus.

Studies have shown that patterns 2 and 3 are the most common, with approximately 45% of cases involving pattern 2 and 35% involving pattern 3.

Another commonly used classification system is the Brodsky and Rouse system. This system describes 3 anatomic Charcot joints (types 1, 2, and 3a and 3b):

  • Type 1 involves the midfoot.
  • Type 2 involves the hindfoot.
  • Type 3a involves the ankle; type 3b is a pathologic fracture of the os calcis tubercle.

The multilevel Schön classification system is also used; it comprises 4 types and characterizes Charcot joints on the basis of sites and degree of involvement.4 All 4 types have 3 subsets (eg, type IA, IB, IC), which are based on the severity of involvement. The 4 types are as follows:

  • Type I - The Lisfranc pattern
  • Type II - The cuneonavicular pattern
  • Type III - The perinavicular pattern
  • Type IV - The transverse tarsal pattern

The Schön classification system allows the prediction of outcomes and the estimation of treatment duration.

Contraindications

The major contraindication to surgery is active inflammation. Studies have shown less favorable outcomes when surgery is performed on an acute joint.

More on Charcot Arthropathy

Overview: Charcot Arthropathy
Workup: Charcot Arthropathy
Treatment: Charcot Arthropathy
Follow-up: Charcot Arthropathy
References

References

  1. Kelly M. William Musgrave's De Arthritide Symptomatica (1703): His description of neuropathic arthritis. Bull Hist Med. 1963;37:372-6.

  2. Charcot JM. Sur quelaques arthropathies qui paraissent depender d'une lesion du cerveau ou de la moele epiniere. Arch Des Physiol Norm et Path. 1868;1:161-71.

  3. Saunders LJ, Mrdjencovich D. Anatomical patterns of bone and joint destruction in neuropathic diabetics. Diabetes. 1991;40:529A.

  4. Schon LC, Easley ME, Weinfeld SB. Charcot neuroarthropathy of the foot and ankle. Clin Orthop. Apr 1998;(349):116-31. [Medline].

  5. Guis S, Pellissier JF, Arniaud D, et al. Healing of Charcot's joint by pamidronate infusion. J Rheumatol. Aug 1999;26(8):1843-5. [Medline].

  6. Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?. Diabet Med. Jan-Feb 1994;11(1):28-31. [Medline].

  7. Strauss E, Gonya G. Adjunct low intensity ultrasound in Charcot neuroarthropathy. Clin Orthop. Apr 1998;(349):132-8. [Medline].

  8. Armstrong DG, Lavery LA. Acute Charcot's arthropathy of the foot and ankle. Phys Ther. Jan 1998;78(1):74-80. [Medline].

  9. Armstrong DG, Lavery LA. Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. J Rehabil Res Dev. Jul 1997;34(3):317-21. [Medline].

  10. Armstrong DG, Todd WF, Lavery LA. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med. May 1997;14(5):357-63. [Medline].

  11. Banks AS, McGlamry ED. Charcot foot. J Am Podiatr Med Assoc. May 1989;79(5):213-35. [Medline].

  12. Brower AC, Allman RM. The neuropathic joint: a neurovascular bone disorder. Radiol Clin North Am. Dec 1981;19(4):571-80. [Medline].

  13. Caputo GM, Ulbrecht J, Cavanagh PR. The Charcot foot in diabetes: six key points. Am Fam Physician. Jun 1998;57(11):2705-10. [Medline][Full Text].

  14. Cavanagh PR, Young MJ, Adams JE. Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care. Mar 1994;17(3):201-9. [Medline].

  15. Cofield RH, Morrison MJ, Beabout JW. Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic change. Foot Ankle. Jul-Aug 1983;4(1):15-22. [Medline].

  16. Frykberg RG, Zgonis T, Armstrong DG, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg. Sep-Oct 2006;45(5 Suppl):S1-66. [Medline].

  17. Gierbolini R. Charcot's foot: often overlooked complication of diabetes. JAAPA. Jun 1999;12(6):62-8. [Medline].

  18. Horwitz T. Bone and cartilage debris in the synovial membrane: its significance in the early diagnosis of neuroarthropathy. J Bone Joint Surg Am. 1948;30:578-88.

  19. Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med. 1936;57:307-12.

  20. Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med. Oct 1989;149(10):2262-6. [Medline].

  21. Klenerman L. The Charcot joint in diabetes. Diabet Med. 1996;13 Suppl 1:S52-4. [Medline].

  22. Morgan JM, Biehl WC 3rd, Wagner FW. Management of neuropathic arthropathy with the Charcot Restraint Orthotic Walker. Clin Orthop. Nov 1993;(296):58-63. [Medline].

  23. Parkhouse N, Le Quesne PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med. May 19 1988;318(20):1306-9. [Medline].

  24. Schauwecker DS. The scintigraphic diagnosis of osteomyelitis. AJR Am J Roentgenol. Jan 1992;158(1):9-18. [Medline].

  25. Sella EJ, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg. Jan-Feb 1999;38(1):34-40. [Medline].

  26. Serra F, Mancini L, Ghirlanda G, et al. Charcot's foot. Rays. Oct-Dec 1997;22(4):524-34. [Medline].

  27. Sinacore DR. Acute Charcot arthropathy in patients with diabetes mellitus: healing times by foot location. J Diabetes Complications. Sep-Oct 1998;12(5):287-93. [Medline].

  28. Sinacore DR, Withrington NC. Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle. J Orthop Sports Phys Ther. Dec 1999;29(12):736-46. [Medline].

  29. Sinha S, Munichoodappa CS, Kozak GP. Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). Medicine (Baltimore). May 1972;51(3):191-210. [Medline].

Further Reading

Keywords

Charcot joint, neuropathic osteoarthropathy, diabetic osteoarthropathy, diabetic neuroarthropathy, Charcot foot, Charcot neuroarthropathy, neuropathic arthropathy, neuropathic joint, Schon classification, Brodsky and Rouse system, Saunders and Mrdjencovich system

Contributor Information and Disclosures

Author

Mrugeshkumar Shah, MD, MPH, Staff Physician, Physical Medicine and Rehabilitation, Massachusetts General Hospital/Spaulding Rehabilitation Hospital
Mrugeshkumar Shah, MD, MPH is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation
Disclosure: Nothing to disclose.

Coauthor(s)

Walter Panis, MD, Clinical Instructor, Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School
Walter Panis, MD is a member of the following medical societies: American Academy of Neurology, American Society of Neurorehabilitation, and Massachusetts Medical Society
Disclosure: Nothing to disclose.

Medical Editor

James K DeOrio, MD, Director of Foot and Ankle Fellowship Program, Assistant Professor of Orthopedic Surgery, Orthopedic Surgery, St. Lukes Hospital, Jacksonville, Florida
James K DeOrio, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Foot and Ankle Society, Florida Medical Association, and German Society of Neurology
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Shepard R Hurwitz, MD, Director of Clinical Services, Department of Orthopedic Surgery, University of Virginia School of Medicine; Director, Division of Foot and Ankle Surgery, Department of Orthopedic Surgery, University of Virginia Health System
Shepard R Hurwitz, MD is a member of the following medical societies: American College of Surgeons, American Orthopaedic Association, American Orthopaedic Foot and Ankle Society, and Orthopaedic Trauma Association
Disclosure: Nothing to disclose.

CME Editor

Dinesh Patel, MD, FACS, Associate Clinical Professor of Orthopedic Surgery, Harvard Medical School; Chief of Arthroscopic Surgery, Department of Orthopedic Surgery, Massachusetts General Hospital
Dinesh Patel, MD, FACS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Association of Physicians of Indian Origin, American College of International Physicians, and American College of Surgeons
Disclosure: Nothing to disclose.

Chief Editor

Jason H Calhoun, MD, FAAOS, Chairman, J Vernon Luck Distinguished Professor, Department of Orthopedic Surgery, University of Missouri
Jason H Calhoun, MD, FAAOS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American College of Surgeons, and American Orthopaedic Foot and Ankle Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.